Miguel Barbosa
Nessuna posizione attualmente
Profilo
Miguel Barbosa served as the Chief Scientific Officer at Mirna Therapeutics, Inc. from 2015 to 2016.
Prior to that, he was the Chief Scientific Officer-Microbiome Program at Assembly Biosciences, Inc. He also worked as the Vice President-Immunology Research at Janssen Research & Development LLC.
Barbosa holds a doctorate degree from the University of California, Los Angeles and an undergraduate degree from the University of California, Davis.
Precedenti posizioni note di Miguel Barbosa
| Società | Posizione | Fine |
|---|---|---|
| ASSEMBLY BIOSCIENCES, INC. | Direttore Tecnico/Scientifico/R&S | 31/10/2017 |
Mirna Therapeutics, Inc.
 Mirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Mirna Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of microRNA-based oncology therapeutics. Its products includes miR-34, miR-215, miR-101, miR-16, and let-7. The company was founded Matthew M. Winkler in 2007 and is headquartered in Austin, TX. | Direttore Tecnico/Scientifico/R&S | 29/06/2016 |
Janssen Research & Development LLC
 Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Part of Johnson & Johnson, Janssen Research & Development LLC is a company that provides research and development medicines and solutions to other medical needs. The company is based in Raritan, NJ. | Corporate Officer/Principal | - |
Formazione di Miguel Barbosa
| University of California, Davis | Undergraduate Degree |
| University of California, Los Angeles | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ASSEMBLY BIOSCIENCES, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Mirna Therapeutics, Inc.
Mirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Mirna Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of microRNA-based oncology therapeutics. Its products includes miR-34, miR-215, miR-101, miR-16, and let-7. The company was founded Matthew M. Winkler in 2007 and is headquartered in Austin, TX. | Commercial Services |
Janssen Research & Development LLC
Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Part of Johnson & Johnson, Janssen Research & Development LLC is a company that provides research and development medicines and solutions to other medical needs. The company is based in Raritan, NJ. | Commercial Services |
- Borsa valori
- Insiders
- Miguel Barbosa
